SCHEMBL9876004

SCHEMBL9876004

Cc1cccc2[nH]nc(C(=O)NC3CC4CCC(C3)N4C)c12

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.55
DYRK1A Q13627 1/20 0.55
ALDH1A1 P00352 1/20 0.52
CYP3A4 P08684 1/20 0.52
TSHR P16473 1/20 0.52
MAPK1 P28482 1/20 0.52
HSD17B10 Q99714 1/20 0.52
HTR3A P46098 8/20 0.51
HTR3E A5X5Y0 3/20 0.51
HTR3B O95264 3/20 0.51
HTR3D Q70Z44 3/20 0.51
HTR3C Q8WXA8 3/20 0.51
SLC22A2 O15244 1/20 0.47
CHRNB2 P17787 1/20 0.47
CHRNA3 P32297 1/20 0.47
CHRNA4 P43681 1/20 0.47
KCNH2 Q12809 1/20 0.47
SLC47A1 Q96FL8 1/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2086084 0.84 NPC1 (0.67) GSK3BDYRK1AALDH1A1CYP3A4TSHR
SCHEMBL7367635 0.82 HTR3E (0.52) CYP3A4HTR3AHTR3EHTR3BHTR3D
Hydrochloric Acid SCHEMBL7306552 0.80 HTR3A (0.64) GSK3BDYRK1AALDH1A1CYP3A4TSHR
Hydrochloric Acid SCHEMBL7306548 0.80 HTR3A (0.64) GSK3BDYRK1AALDH1A1CYP3A4TSHR
SCHEMBL2086948 0.80 NPC1 (0.68) GSK3BDYRK1AALDH1A1CYP3A4TSHR
SCHEMBL12441936 0.80 NPC1 (0.68) GSK3BDYRK1AALDH1A1CYP3A4TSHR
SCHEMBL2087490 0.80 NPC1 (0.68) GSK3BDYRK1AALDH1A1CYP3A4TSHR
Trifluoroacetic Acid SCHEMBL17163426 0.78 NPC1 (0.60) GSK3BDYRK1AALDH1A1CYP3A4TSHR
Trifluoroacetic Acid SCHEMBL17163423 0.78 NPC1 (0.60) GSK3BDYRK1AALDH1A1CYP3A4TSHR
SCHEMBL19236410 0.78 NPC1 (0.62) GSK3BDYRK1AALDH1A1CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0422154-A1 THERAPEUTIC USE OF 5-HT3 RECEPTOR ANTAGONISTS. SANDOZ AG (AT) 1991-04-17 EP claimed
WO-1990012569-A1 THERAPEUTIC USE OF 5-HT3 RECEPTOR ANTAGONISTS SANDOZ AG (CH) 1990-11-01 WO claimed
EP-0422154-A1 THERAPEUTIC USE OF 5-HT3 RECEPTOR ANTAGONISTS. SANDOZ AG (AT) 1991-04-17 EP disclosed
WO-1990012569-A1 THERAPEUTIC USE OF 5-HT3 RECEPTOR ANTAGONISTS SANDOZ AG (CH) 1990-11-01 WO disclosed